Cargando…

Randomized Phase 3 Trial of Ruxolitinib for COVID-19–Associated Acute Respiratory Distress Syndrome*

Evaluate the safety and efficacy of the Janus kinase (JAK)1/JAK2 inhibitor ruxolitinib in COVID-19–associated acute respiratory distress syndrome requiring mechanical ventilation. DESIGN: Phase 3 randomized, double-blind, placebo-controlled trial Ruxolitinib in Participants With COVID-19–Associated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rein, Lindsay, Calero, Karel, Shah, Ronak, Ojielo, Charles, Hudock, Kristin M., Lodhi, Saba, Sadaka, Farid, Bellam, Shashi, Palma, Christopher, Hager, David N., Daniel, Jeannie, Schaub, Richard, O’Hayer, Kevin, Theodoropoulos, Nicole M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Feature Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668361/ https://www.ncbi.nlm.nih.gov/pubmed/36226977 http://dx.doi.org/10.1097/CCM.0000000000005682

Ejemplares similares

Acceptance and Commitment Therapy with Pancreatic Cancer: An Integrative Model of Palliative Care—A Case Report
por: O'Hayer, Catherine Virginia F., et al.
Publicado: (2018)

Managing Moral Distress in the Workplace:: Creating a Resiliency Bundle
por: Davis, Melodie, et al.
Publicado: (2020)

Moral Distress in the ICU: Measuring, Tracking, and Responding to Staff Experiences
por: Eddleman, Matthew, et al.
Publicado: (2023)

Building a Life Worth Living During a Pandemic and Beyond: Adaptations of Comprehensive DBT to COVID-19()
por: O'Hayer, C. Virginia
Publicado: (2021)

Revising the Diabetes Distress Scale for Use Among Adults in the Dominican Republic: Findings From Cognitive Interviews
por: Wallace, Deshira D., et al.
Publicado: (2022)

Ruxolitinib in myelofibrosis: to be or not to be an immune disruptor
por: Manduzio, Palma
Publicado: (2017)

Is It Distress, Depression, or Both? Exploring Differences in the Diabetes Distress Scale and the Patient Health Questionnaire in a Diabetes Specialty Clinic
por: Wardian, Jana L., et al.
Publicado: (2019)

Acute respiratory distress syndrome; A rare complication caused by usage of ruxolitinib
por: Kerget, Bugra, et al.
Publicado: (2017)

An intraorganizational model for developing and spreading quality improvement innovations
por: Kellogg, Katherine C., et al.
Publicado: (2017)

Ruxolitinib for myelofibrosis
por: GU, LIAN, et al.
Publicado: (2013)

Psychological distress and resilience among italian healthcare workers of geriatric services during the COVID-19 pandemic
por: Mangialavori, Sonia, et al.
Publicado: (2022)

Promising results from a pilot study to reduce distress in Vietnamese American dementia and memory loss caregivers
por: Ta Park, Van M., et al.
Publicado: (2019)

Levelling the playing field: Exploring inequalities and exclusions with a community‐based football league for people with experience of mental distress
por: Pettican, Anna, et al.
Publicado: (2022)

Ruxolitinib: Thrombocytopenia following compassionate use of ruxolitinib: 2 case reports
Publicado: (2022)

Ruxolitinib for the treatment of SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)
por: Neubauer, Andreas, et al.
Publicado: (2020)

Acute respiratory distress syndrome in a patient with primary myelofibrosis after ruxolitinib treatment discontinuation
por: Beauverd, Yan, et al.
Publicado: (2014)

HER-2-Positive Ampullary Adenocarcinoma: A Case Report
por: O'Hayer, Kevin, et al.
Publicado: (2015)

A Best Practices Case Study for Scientific Collaboration between Researchers and Managers
por: Newcomb, Tammy J., et al.
Publicado: (2020)

Ruxolitinib for essential thrombocythemia?
por: Bose, Prithviraj, et al.
Publicado: (2017)

Reducing Social Distress for Chronic Disease Patients in Primary Care: An Intervention for Latino Type 2 Diabetes Patients Seen at Community Health Centers
por: Allen, Nancy A., et al.
Publicado: (2017)

A clinician’s view of public health care in Quebec
por: Saba, Paul, et al.
Publicado: (2008)

Provider experiences of virtual reality in clinical treatment
por: Vincent, Christine, et al.
Publicado: (2021)

Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?
por: Caocci, Giovanni, et al.
Publicado: (2020)

Fatal spontaneous rectus sheath hematoma in a patient with cirrhosis
por: McCarthy, Danielle M, et al.
Publicado: (2010)

Alzheimer's disease medication and risk of all-cause mortality and all-cause hospitalization: A retrospective cohort study
por: Bhattacharjee, Sandipan, et al.
Publicado: (2019)

A systematic review on factors and consequences of parental distress as related to childhood cancer
por: Sultan, S., et al.
Publicado: (2015)

The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)
por: Neubauer, Andreas, et al.
Publicado: (2021)

The Use of Nitric Oxide as a Rescue Modality for Severe Adult Acute Respiratory Distress Syndrome Patients, Including COVID-19, in Critical Care Rotor Transport: A Retrospective Community Outcome Study
por: Piecek, Jason, et al.
Publicado: (2022)

Ruxolitinib in Myelofibrosis and Polycythemia Vera
por: Wolfe, Leah
Publicado: (2016)

Coccidioidomycosis in Patients Treated With Ruxolitinib
por: Kusne, Yael, et al.
Publicado: (2020)

Ruxolitinib for the Treatment of Essential Thrombocythemia
por: Gunawan, Arief, et al.
Publicado: (2018)

Ruxolitinib and Severe COVID-19
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

The Landscape of Pancreatic Cancer Therapeutic Resistance Mechanisms
por: Chand, Saswati, et al.
Publicado: (2016)

Thrombocytopenia: A possible side effect of apixaban
por: Sadaka, Farid
Publicado: (2019)

No Place for Predators?: Time and again, advancing civilization has set people against large carnivores. On the front lines of Washington State, wildlife biologists hope that knowledge can trump fear, and ultimately lead to détente.
por: Gross, Liza
Publicado: (2008)

Transplant Biology at a Crossroads: Surgeons can now give patients a new hand or even a new face, but they still can't provide any guarantees that the benefits are worth the risks.
por: Sedwick, Caitlin
Publicado: (2008)

Arctic Sentinels: Global mercury emissions have stabilized over the past decade, yet levels in Arctic marine mammals have risen by an order of magnitude. Scientists struggle to explain why.
por: Hoag, Hannah
Publicado: (2008)

Cancer coverage: the public face of childhood leukaemia in 1960s Britain
por: Barnes, Emm
Publicado: (2008)

Across the Curious Parallel of Language and Species Evolution
por: Whitfield, John
Publicado: (2008)

Sorcerer II: The Search for Microbial Diversity Roils the Waters
por: Nicholls, Henry
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_t3todjr0h95cj58tshs8m4km4b